Previous close | 6.10 |
Open | 6.10 |
Bid | 14.90 |
Ask | 18.30 |
Strike | 77.50 |
Expiry date | 2026-01-16 |
Day's range | 6.10 - 6.10 |
Contract range | N/A |
Volume | |
Open interest | 16 |
Edwards Lifesciences stock plummeted Thursday after the medtech cut its outlook for TAVR sales following a mixed second-quarter report.
FEATURE Shares of Edwards Lifesciences fell sharply after the medical-technologies company’s quarterly earnings report and guidance left investors disappointed. For its second quarter, ended June 30, the company reported adjusted earnings per share of 70 cents, beating Wall Street’s forecast by a penny, according to FactSet.
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.